2022-001751-17
Multicenter, randomized, double-blind, placebo-controlled clinical trial evaluating the efficacy and safety of donepezil versus placebo in mild cognitive impairment associated with Parkinson's disease
Institut de Recerca Hospital de la Santa Creu i Sant Pau - IIB Sant Pau·EU Clinical Trials RegisterOngoing
Study focus
- Disease/Condition
- Parkinson's disease
Sponsor & location
- Primary sponsor
- Institut de Recerca Hospital de la Santa Creu i Sant Pau - IIB Sant Pau
- Funder
- Instituto de Salud Carlos III
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
Parkinson's Disease-Cognitive Rating Scale (PD-CRS):
ICD-10 classifications
Parkinson diseaseParkinsonism in diseases classified elsewhereDementia in Parkinson diseaseSecondary parkinsonismPostencephalitic parkinsonism
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2022-001751-17
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2022-001751-17 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut de Recerca Hospital de la Santa Creu i Sant Pau - IIB Sant Pau and is currently Ongoing. The study focuses on Parkinson's disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.